Background: Thrombosis is a common complication associated with central venous catheter (CVC) insertion. Several antithrombogenic materials and alterations to catheter design have been developed to lower thrombosis rates. Aim: To systematically evaluate the effectiveness and safety of antithrombogenic materials and alterations to CVC design on thrombosis rates. Methods: A systematic search was completed of main databases (CINAHL, EMBASE, MEDLINE, and PubMed) as well as trial registries and gray literature. Randomized controlled trials conducted in any age group, published in English language since 2008 reporting impact of different CVC designs or materials on thrombosis were included, to capture studies that reflect contemporary products an...
BackgroundThe objective of this systematic review is to determine the extent and quality of evidence...
Introduction: Thrombotic complications associated with peripherally inserted central catheters (PICC...
This study reports on a block clinical trial of two types of central venous catheters (CVCs): antise...
Background: Central venous catheters are commonly used in healthcare, but they come with a range of ...
OBJECTIVE: To test the evidence that the risk of infection related to central venous catheters (CVCs...
Background: Central venous catheters (CVCs) play a vital role in the management of acute and chronic...
Background: Bloodstream infection related to a central venous catheter is a substantial clinical and...
Introduction: Thrombosis and infections are well known complications of central venous catheters and...
To identify patient-related risk factors for venous thrombosis in patients with central venous cathe...
. Central venous catheters are extensively used in patients with cancer to secure delivery of chemot...
Background: Bloodstream infection related to a central venous catheter is a substantial clinical and...
Randomized controlled trials evaluate the effectiveness of interventions for central venous access d...
Objective: to determine the efficacy of double-lumen central venous catheters coated with chlorhexid...
Background. The efficacy of antimicrobial central venous catheters (CVCs) remains questionable. In t...
PurposeThe CATheter infections in CHildren (CATCH) trial reported reduced risks of bloodstream infec...
BackgroundThe objective of this systematic review is to determine the extent and quality of evidence...
Introduction: Thrombotic complications associated with peripherally inserted central catheters (PICC...
This study reports on a block clinical trial of two types of central venous catheters (CVCs): antise...
Background: Central venous catheters are commonly used in healthcare, but they come with a range of ...
OBJECTIVE: To test the evidence that the risk of infection related to central venous catheters (CVCs...
Background: Central venous catheters (CVCs) play a vital role in the management of acute and chronic...
Background: Bloodstream infection related to a central venous catheter is a substantial clinical and...
Introduction: Thrombosis and infections are well known complications of central venous catheters and...
To identify patient-related risk factors for venous thrombosis in patients with central venous cathe...
. Central venous catheters are extensively used in patients with cancer to secure delivery of chemot...
Background: Bloodstream infection related to a central venous catheter is a substantial clinical and...
Randomized controlled trials evaluate the effectiveness of interventions for central venous access d...
Objective: to determine the efficacy of double-lumen central venous catheters coated with chlorhexid...
Background. The efficacy of antimicrobial central venous catheters (CVCs) remains questionable. In t...
PurposeThe CATheter infections in CHildren (CATCH) trial reported reduced risks of bloodstream infec...
BackgroundThe objective of this systematic review is to determine the extent and quality of evidence...
Introduction: Thrombotic complications associated with peripherally inserted central catheters (PICC...
This study reports on a block clinical trial of two types of central venous catheters (CVCs): antise...